Forest Laboratories "neutral" reiterated
New Ratings - 17 Jan 2003
The analysts believe that higher Celexa/Lexapro volumes and lower spending more
than offset the reduced incomes from Forest Laboratories’ other segments ...

Forest Labs "buy;" target price raised
New Ratings - 17 Jan 2003
According to Thomas Weisel Partners’ research note, sales of Celexa and Lexapro
have been strong and were responsible for fuelling the Sept 2002 growth. ...

US Late Market Comment -5: Watson Gains, Forest Falls
Yahoo News - 16 Jan 2003
... a pullback, dropping 1.22, or 2.2%, to 53.43 after fiscal third-quarter net income
doubled on strong sales of its antidepressant medications, Celaxa and Lexapro ...

Roundup: GM cruises
CNN Europe, Europe - 16 Jan 2003
... NEW YORK (Reuters) -- The drugmaker posted a sharp rise in quarterly earnings,
fueled by strong sales of its antidepressants Celexa and Lexapro. ...

Forest Labs Profit Up on Antidepressants
ABC News - 16 Jan 2003
... Laboratories Inc. said on Thursday quarterly earnings doubled, fueled
by strong sales of antidepressants Celexa and Lexapro. The ...

Forest Labs Profit Up on Antidepressants
Reuters, UK - 16 Jan 2003
... Laboratories Inc. FRX.N said on Thursday quarterly earnings doubled,
fueled by strong sales of antidepressants Celexa and Lexapro. The ...

Celexa, Lexapro Sales Boost Forest Labs' Quarter
TheStreet.com, NY - 16 Jan 2003
... million. Forest's anti-depressant franchise -- Celexa and Lexapro --
contributed $452.2 million in sales during the quarter. Looking ...

Danish shares close lower , tracking European markets ; B&O up on ...
AFX Press - 15 Jan 2003
... pct a week earlier, brokers said. The market share of the new Lexapro
rose, while Celexa fell, they added. Novo Nordisk B shed 2.5 ...

RENEGADE REPORT
CBS MarketWatch - 06 Jan 2003
... Goodman told the gathering that the company's introduction of a new antidepressant,
Lexapro, has been "one of the most successful product launches in the ...

S&P Ups Forest Labs to Accumulate
BusinessWeek - 03 Jan 2003
... sees earnings per share for the third quarter of fiscal 2003 (March) at least 15%
above the consensus of 77 cents, driven by surging sales of Celexa/Lexapro ...

Home Depot a Party Pooper
Smart Money - 03 Jan 2003
... rose 5% after the company pledged to beat analysts' third-quarter profit projections
by at least 15% thanks to strong sales of mindbenders Celexa and Lexapro. ...

Take a pill to curb shopping urge
Arizona Daily Star, AZ - 03 Jan 2003
... They also began a Forest-funded study testing the effects of its new
antidepressant, Lexapro, on compulsive shopping in December. ...

Take a pill to curb shopping urge
DailyStar.com - 03 Jan 2003
... They also began a Forest-funded study testing the effects of its new
antidepressant, Lexapro, on compulsive shopping in December. ...

Forest Labs Surges on Strong Outlook
TheStreet.com, NY - 02 Jan 2003
... quarter. Sales of the antidepressant Lexapro, launched in September,
should total about $80 million in the quarter, the company said. ...

Forest Labs expects to exceed 3rd-quarter forecast
Forbes - 02 Jan 2003
... will be about $585 million, fueled by projected sales of $370 million for Celexa
and sales of about $80 million for Forest's newer antidepressant, Lexapro ...